Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
01.10.25
/
50%
€115.08
Target price
01.10.26
€133.73
Performance (%)
-29.08%
Price
13:55
€81.62
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -29.08%. This prediction currently runs until 01.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 5.569% | 5.569% |
| iShares Core DAX® | -1.427% | -1.427% |
| iShares Nasdaq 100 | -1.979% | 0.174% |
| iShares Nikkei 225® | -3.848% | 6.534% |
| iShares S&P 500 | -0.472% | 0.237% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $153.00 to $157.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€87.50
08.04.26
08.04.26
€103.67
08.04.27
08.04.27
-6.72%
13:55
13:55
Abbott Laboratories
Start price
Target price
Perf. (%)
€92.26
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
-11.53%
13:55
13:55
Abbott Laboratories
Start price
Target price
Perf. (%)
€106.22
15.01.26
15.01.26
€130.60
15.01.27
15.01.27
-23.71%
13:55
13:55
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-26.88%
05.03.26
05.03.26